Search For "pharmaceutical company"
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More
Fire breaks out outside pharmaceutical company in Visakhapatnam
Updated : 5 years, 7 months ago IST
Visakhapatnam (Andhra Pradesh) [India], Aug 4 (ANI): A fire broke out outside a pharma company in Andhra Pradesh's Visakhapatnam district on Tuesday morning. No injuries have been reported in the incident.
Read More
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 21 (ANI/PRNewswire): In response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.
Read More
Mylan announces commercial launch of its Remdesivir under brand name DESRE
Updated : 5 years, 7 months ago IST
New Delhi/Bengaluru [India], July 20 (ANI): Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREM™ in India to address urgent, unmet needs amid COVID-19 pandemic.
Read More
5-member probe team appointed by district collector submits report on Viza
Updated : 5 years, 8 months ago IST
Visakhapatnam (Andhra Pradesh) [India], July 15 (ANI): A five-member committee appointed by District Collector Vinay Chand, to probe into Monday night's fire incident at a pharmaceutical company in the JN Pharma City at Parawada here, submitted its preliminary report on Tuesday evening.
Read More
1 injured in fire at Visakhapatnam pharma company
Updated : 5 years, 8 months ago IST
Visakhapatnam (Andhra Pradesh) [India], July 14 (ANI): At least one person was injured in a fire that broke out at a pharmaceutical company in JN Pharma City at Parawada in Visakhapatnam late on Monday night, police said.
Read More
Fire breaks out at pharma company in Visakhapatnam
Updated : 5 years, 8 months ago IST
Visakhapatnam (Andhra Pradesh) [India], July 14 (ANI): A massive fire broke out at a pharmaceutical company in JN Pharma City at Parawada in Visakhapatnam late on Monday night.
Read More
Glenmark commences 1000 patients Post Marketing Surveillance study with CO
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in
Read More
Brazil announces agreement with UK to produce COVID-19 vaccine
Updated : 5 years, 8 months ago IST
Sao Paulo [Brazil], June 28 (Xinhua/ANI): The Brazilian Ministry of Health on Saturday announced an agreement with the United Kingdom to acquire technology to locally produce a vaccine against COVID-19, that is, currently being developed by the University of Oxford and British pharmaceutical
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More